Bone Quality and Fractures in Women With Osteoporosis Treated With Bisphosphonates for 1 to 14 Years

Oral bisphosphonates are the primary medication for osteoporosis, but concerns exist regarding potential bone‐quality changes or low‐energy fractures. This cross‐sectional study used artificial intelligence methods to analyze relationships among bisphosphonate treatment duration, a wide variety of b...

Descripción completa

Detalles Bibliográficos
Autores principales: Malluche, Hartmut H, Chen, Jin, Lima, Florence, Liu, Lucas J, Monier‐Faugere, Marie‐Claude, Pienkowski, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567493/
https://www.ncbi.nlm.nih.gov/pubmed/34761151
http://dx.doi.org/10.1002/jbm4.10549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567493/
https://www.ncbi.nlm.nih.gov/pubmed/34761151
http://dx.doi.org/10.1002/jbm4.10549

Ejemplares similares